Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey.
Kate GrindlayKatherine KeyCarmela ZunigaAlexandra WollumDaniel GrossmanKelly BlanchardPublished in: BMJ sexual & reproductive health (2022)
Overall, OTC POP users in a trial setting found the menstrual bleeding acceptable and the method similar to or better than previous methods. POP labelling should provide clear messaging about bleeding changes users may experience.